David Mazzo, CEO, Director at Lisata Therapeutics, holds 174.77K shares in Lisata Therapeutics (Ticker: LSTA), holds ― shares in Palisade Bio (Ticker: PALI), holds 200.08K shares in EyePoint Pharmaceuticals (Ticker: EYPT).
What is the percentage of profitable transactions made by David Mazzo?
The percentage of profitable transactions made by David Mazzo is 0%.
What is the average return per transaction made by David Mazzo?
The average return per transaction made by David Mazzo is -50.20%.
What stocks does David Mazzo hold?
David Mazzo holds: LSTA, PALI, EYPT, TBRA, AVNR stocks.
What was David Mazzo’s latest transaction?
David Mazzo latest transaction was an Uninformative Sell of $3.07K.
What was David Mazzo's most profitable transaction?
David Mazzo’s most profitable transaction was an Informative Buy of EYPT stock on April 24, 2018. The return on the trade was -14.50%.
What is David Mazzo's role in Lisata Therapeutics?
David Mazzo's role in Lisata Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.